Stock BD1 BAR1 LIFE
Add to a list
To use this feature you must be a member
Log inSign up

Financials BAR1 LIFE Australian S.E.

Equities

BD1

Biotechnology & Medical Research

End-of-day quote Australian S.E.
Other stock markets
 		5-day change 1st Jan Change
- AUD -.--% Intraday chart for BAR1 LIFE -.--% -.--%
04-19 INOVIQ Concludes Analytical Validation for Ovarian Cancer Blood Test MT
04-15 Fears of Middle East Conflict Escalation Quell Appetite for Australian Shares MT

Valuation

Fiscal Period: June 2023 2024 2025 2026
Capitalization 1 78.22 50.15 - -
Enterprise Value (EV) 1 78.22 43.05 41.25 43.55
P/E ratio -8.72 x -5.56 x -7.27 x -17 x
Yield - - - -
Capitalization / Revenue - 55.7 x 31.3 x 6.12 x
EV / Revenue - 47.8 x 25.8 x 5.31 x
EV / EBITDA - -5.59 x -5.81 x -16.1 x
EV / FCF - -5.25 x -5.65 x -15 x
FCF Yield - -19% -17.7% -6.66%
Price to Book - 2.73 x 2.73 x 5.45 x
Nbr of stocks (in thousands) 92,019 92,019 - -
Reference price 2 0.8500 0.5450 0.5450 0.5450
Announcement Date 8/29/23 - - -
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2023 2024 2025 2026
Net sales 1 - 0.9 1.6 8.2
EBITDA 1 - -7.7 -7.1 -2.7
EBIT 1 - -9 -8.4 -3.9
Operating Margin - -1,000% -525% -47.56%
Earnings before Tax (EBT) 1 - -9 -8.4 -3.9
Net income 1 -8.969 -9 -8.4 -3.9
Net margin - -1,000% -525% -47.56%
EPS 2 -0.0975 -0.0980 -0.0750 -0.0320
Free Cash Flow 1 - -8.2 -7.3 -2.9
FCF margin - -911.11% -456.25% -35.37%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 8/29/23 - - -
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2023 2024 2025 2026
Net Debt 1 - - - -
Net Cash position 1 - 7.1 8.9 6.6
Leverage (Debt/EBITDA) - - - -
Free Cash Flow 1 - -8.2 -7.3 -2.9
ROE (net income / shareholders' equity) - - - -
ROA (Net income/ Total Assets) - - - -
Assets 1 - - - -
Book Value Per Share 2 - 0.2000 0.2000 0.1000
Cash Flow per Share 2 - -0.0700 -0.0600 -0.0200
Capex 1 - 0.5 0.2 0.2
Capex / Sales - 55.56% 12.5% 2.44%
Announcement Date 8/29/23 - - -
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
MODERNA, INC. Stock Moderna, Inc.
+29.03% 49.18B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-0.10% 42.11B
LONZA GROUP AG Stock Lonza Group AG
+47.87% 40.37B
CELLTRION, INC. Stock Celltrion, Inc.
-5.26% 28.85B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.48% 26.09B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-22.74% 18.71B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+9.06% 13.26B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+30.01% 12.32B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-1.51% 11.99B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. IIQ Stock
  4. BD1 Stock
  5. Financials BAR1 LIFE
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW